Evaluation of commercially available anti-dengue virus immunoglobulin M tests
UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases & Pediatric Dengue Vaccine Initiative. (2009). Evaluation of commercially available anti-dengue virus immunoglobulin M tests. World Health Organization. http://www.who.int/iris/handle/10665/44067
Diagnostics evaluation series ; no. 3
MetadataShow full item record
Showing items related by title and MeSH subject.
Evaluation of Immunoglobulin A-capture Enzyme-linked Immunosorbent Assay for Serodiagnosis of Dengue Virus Infection. Nawa, Masaru; Pan, Chao-Ying; Tsai, Wu-hsiung; Chan, Chaur-don; Machida, Sanae; Takasaki, Tomohiko; LIm, Chang-Kweng; Harn, Ming-Rong; Kurane, Ichiro (2006-12)
Discrimination between primary and secondary dengue virus infection by using an immunoglobulin G avidity test. Chakravarti, A; Matlani, M; Kumar, A (2008-12)Discrimination between primary and secondary dengue infections is important, as the possibility ofDHF is more in secondary infection. Therefore, there is need to develop a test that can distinguishbetween primary and secondary serological responses. The traditionally-used haemagglutinationinhibition (HI) test, which is recommended by the World Health Organization, is complicated toperform. We standardized an enzyme-linked immunosorbent assay kit with some modifications todiscriminate between primary and secondary dengue infections. Sera from 72 ...